Wird geladen...

Circulating Tumor DNA‐Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma

PURPOSE: Recent advances in molecular diagnostic technologies allow for the evaluation of solid tumor malignancies through noninvasive blood sampling, including circulating tumor DNA profiling (ctDNA). Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, often because of late presentation o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncologist
Hauptverfasser: Botrus, Gehan, Kosirorek, Heidi, Sonbol, Mohamad Bassam, Kusne, Yael, Uson Junior, Pedro Luiz Serrano, Borad, Mitesh J., Ahn, Daniel H., Kasi, Pashtoon M., Drusbosky, Leylah M., Dada, Hiba, Surapaneni, Phani Keerthi, Starr, Jason, Ritter, Ashton, McMillan, Jessica, Wylie, Natasha, Mody, Kabir, Bekaii‐Saab, Tanios S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley & Sons, Inc. 2021
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8265372/
https://ncbi.nlm.nih.gov/pubmed/33555095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13717
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!